description

Sanofi and Regeneron Pharmaceuticals said they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent. Reuters reports the new list price for Praluent will be $5,850 a year, matching the price Amgen set when it lowered the list of its competing drug, Repatha, in October. Sanofi and Regeneron said they expect the lower-priced Praluent to be available for pharmacies to order in early March.

general info

  • Uploaded    02/11/2019
  • News & Politics
  • Sant Jordi, la tradición de regalar rosas y libros
  • Британские пожарные пытаются потушит...
  • США хотят полностью запретить импорт ...
  • Myanmar top court rejects final appeal of Reuters reporters
  • Video shows suspected suicde bomber entering Sri Lankan church
  • بعد أسبوع على حادث نوتردام.. السائحون ي...
  • القارب الهيدروجيني يبحر إلى أمستردام ...
  • Brutal pelea de dos bandas de narcotraficantes en plena calle en Barce...
  • Россияне надеются на улучшение отноше...